MSKCC, IBM Developing Tool for Personalized Cancer Diagnosis and Treatment | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Memorial Sloan-Kettering Cancer Center in New York and IBM today announced they will work together to develop a tool to help doctors create individualized cancer diagnostic and treatment recommendations based on current evidence.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.